AMPH vs MAS · P/E 12, rev $732.0M vs P/E 18, rev $7.83B
Amphastar P (AMPH) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the AMPH and MAS stock pages for the full models.
Not investment advice.